Building on recent breakthroughs in gene therapy, 2025 is poised for major advancements in cell transplants, gamma secretase inhibitors, anti-inflammatory programs, and more to address the growing unmet need for more transformative hearing loss treatments.

With an aging population and an urgent need to restore a greater spectrum of hearing abilities beyond the scope of current device-based interventions, there has never been a more critical time for the field to unite and drive progress.

Coined by industry as the only meeting of its kind, uniquely positioned to share fresh ideas and assess viable approaches to your most pressing preclinical, translational, and clinical bottlenecks, the 5th Inner Ear Disorders Therapeutics Summit returns as your definitive forum to benchmark learnings from past failures and ignite renewed optimism into the hearing loss therapeutic landscape.

With pioneering insights from Regeneron, Biogen, Acousia, Rinri, Ting Therapeutics, Lineage Cell Therapeutics, Gateway and more, join 50+ of your peers to:

• Advance translatable models to recapitulate complex human inner ear pathophysiology
• Deepen knowledge of molecular and genetic pathways underlying age-related, noise-induced, and congenital hearing loss to uncover druggable pathways
• Evaluate clinical progress in gene therapy for restored hearing and decipher the journey to success in Phase III populations
• Overcome translational challenges of bringing advanced therapies, including small molecule and cell-based approaches, to the clinic
• Uncover opportunities for drug-device combinations to enable precise drug delivery and enhance the hearing preservation capabilities of cochlear implants
• Hear large pharma and investor perspectives on what must be demonstrated to de-risk business opportunities within the hearing disorders space

Join this unparalleled forum of biotech innovators, pharma stakeholders, medical device manufacturers, and leading academics in a collaborative atmosphere to advance otoprotection, hearing restoration, and gene therapy R&D and transform the treatment of hearing loss.

Find out more in our brochure: https://ter.li/22rawz